Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over the United States' request for confidential information.
The decision became public after a internal memorandum dated December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the arrangement was "skewed".
An official representative has since clarified that the United States was seeking biological samples for scientific study and profit but was unwilling to guarantee the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for continued negotiations to reach a deal acceptable to all parties so the country's critical HIV programme can continue.
Broader Context
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court suspended a related deal with the US after concerns were raised about the security of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government deals to enhance openness and accountability.
Based on statements, Sixteen nations in Africa have so far signed similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to provide its biological resources and data indefinitely, with no corresponding assurance of access to any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.
"In essence, our country would supply the basic resources for scientific discovery without any assurance that the final treatments would be accessible to our people if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining structures already set up via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential global health emergencies.
"This mechanism is intended to ensure that when a nation provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
The government's concerns over the US deal "must not be interpreted as opposition to America," he added.
"We encourage continued dialogue with our US partners on how future co-operation could be designed in a way that honours the independence and interests of each country."
Medical Community Response
A leading public health body expressed it recognised the official position, but recommended that negotiations should continue given that much of the country's HIV programmes depended on external financing.
"If specific concerns arise, including those involving data governance or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," it added.
The situation highlights the ongoing debate between accepting vital international aid and safeguarding national sovereignty in an increasingly interconnected world.